share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Donoghoe Nicholas

AbbVie | 4: Statement of changes in beneficial ownership of securities

艾伯维公司 | 4：持股变动声明
SEC announcement ·  03/22 17:03
Moomoo AI 已提取核心信息
Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc. (ABBV), completed a sale of 21,082 shares of common stock on March 20, 2024. The shares were sold at a price of $176.3 each, resulting in a total transaction value of $3,716,756.60. Following the transaction, Donoghoe directly holds 55,903 shares of the company. The sale was conducted as an open market or private sale, and the transaction has been reported as completed.
Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc. (ABBV), completed a sale of 21,082 shares of common stock on March 20, 2024. The shares were sold at a price of $176.3 each, resulting in a total transaction value of $3,716,756.60. Following the transaction, Donoghoe directly holds 55,903 shares of the company. The sale was conducted as an open market or private sale, and the transaction has been reported as completed.
艾伯维公司（ABBV）执行副总裁兼首席公共汽车/战略官尼古拉斯·多诺霍于2024年3月20日完成了21,082股普通股的出售。这些股票以每股176.3美元的价格出售，总交易价值为3,716,756.60美元。交易完成后，Donoghoe直接持有该公司的55,903股股份。此次出售是以公开市场或私人销售的形式进行的，据报告交易已完成。
艾伯维公司（ABBV）执行副总裁兼首席公共汽车/战略官尼古拉斯·多诺霍于2024年3月20日完成了21,082股普通股的出售。这些股票以每股176.3美元的价格出售，总交易价值为3,716,756.60美元。交易完成后，Donoghoe直接持有该公司的55,903股股份。此次出售是以公开市场或私人销售的形式进行的，据报告交易已完成。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息